Cargando…
Inhaled iloprost can improve oxygenation and shunt fraction in severe COVID-19
Autores principales: | Serbanescu-Kele Apor de Zalán, Christiaan M.C., Foudraine, Norbert A., Le Noble, Jos L.M.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Critical Care Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918720/ https://www.ncbi.nlm.nih.gov/pubmed/35279981 http://dx.doi.org/10.4266/acc.2021.01263 |
Ejemplares similares
-
Iatrogenic topiramate poisoning in an ICU patient: Focus on topiramate peak time prolongation
por: Hoebregts, Vera M.G., et al.
Publicado: (2021) -
Inhaled iloprost for the control of pulmonary hypertension
por: Krug, Sabine, et al.
Publicado: (2009) -
Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation
por: Serbanescu-Kele Apor de Zalán, Christiaan M. C., et al.
Publicado: (2022) -
The unfriendly side of “happy hypoxaemia”: Sudden cardiac death
por: Serbanescu-Kele Apor de Zalán, C.M.C., et al.
Publicado: (2022) -
Inhaled iloprost for the treatment of patient with Fontan circulation
por: Kim, Yong Hyun, et al.
Publicado: (2014)